Last updated: May 22, 2025
Sponsor: Universität des Saarlandes
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pain (Pediatric)
Treatment
Placebo
Probiotics
Clinical Study ID
NCT03773003
IMPROFA
Ages 18-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
histologically, cytologically or radiologically confirmed tumor disease
indication for chemotherapy
Written consent to participation
Exclusion
Exclusion Criteria:
chronic-inflammatory bowel disease
pregnancy
Study Design
Total Participants: 150
Treatment Group(s): 2
Primary Treatment: Placebo
Phase:
Study Start date:
July 20, 2021
Estimated Completion Date:
December 01, 2025
Study Description
Connect with a study center
Saarland University Medical Center
Homburg, Saarland 66424
GermanyActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.